STADA Arzneimittel AG Enters Exclusive Medical Cannabis Partnership with MediPharm Labs Corp Investor Call Transcript

Oct 05, 2020 / 02:30PM GMT
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the MediPharm Labs conference call. (Operator Instructions)

Please be advised that today's conference is being recorded. (Operator Instructions)

I would now like to turn the call over to Laura Lepore, Vice President. Please go ahead.

Laura Lepore - MediPharm Labs Corp. - VP of IR & Communications

Thanks, operator, and good morning, everyone. Thanks for joining us. With me on the call today are Pat McCutcheon, Chief Executive Officer; Keith Strachan, President; and Bobby Kwon, our Chief Financial Officer.

Now before we begin, please note the cautions reflecting forward-looking information, which is made on behalf of MediPharm Labs and all of its representatives on the call.

The oral statements made on this call will contain forward-looking information that involves risks and uncertainties, including those introduced by the COVID-19 pandemic.

Actual results could differ materially from a conclusion, forecast or projection in the forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot